arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Theravance Biopharma, Inc.

TBPH

$16.92 ▲ +0.02 (+0.12%) at close

15 Visible periods

32 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Excellent

Bullish

auto_awesome

Analytical Summary

Theravance Biopharma, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%) and Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $851.4M

Dividend Yield —

Revenue Growth 66.9% ↗

Op. Margin -3.4% ↗

ROIC -1.0% ↗

FCF / Share $4.74 ↗

Trailing P/E 8.1x

Price / Book 2.9x

FCF Yield 28.0%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

15-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$107.46M

↑ +66.9% —

Net Income Profit after all expenses

$105.89M

↑ +287.7% —

Operating Margin Operating profit as % of sales

-3.4%

↑ +95.4% 22th

FCF / Share Free cash flow per share

$4.74

↑ +2107.6% —

Long-Term Debt Long-term obligations

$0.00

↓ -100.0% —

trending_up

Bullish Indicators

Profit Margin (%)Profit Margin (%) is in the top quartile
Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue Growth YoY (%)	66.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+736%)	12.1% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+51%)	11.8% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+48%)	-7.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-190%)	-23.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-388%)	-2.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-127%)	21.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+170%)	292.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3555%)	-68.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-955%)	15.5% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+94%)	260.4% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+3155%)	5071.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+63296%)	-99.8% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1348%)	—	—
EPS Growth YoY (%)	N/M	-15.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	35.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	-2.2% Weak Weak Year-over-year change in net income	N/M	N/M	28.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-17.6% Weak ↓ Weak Declining Year-over-year change in net income	-9.7% Weak → Weak Stable Year-over-year change in net income	24.5% Good ↑ Good Improving Year-over-year change in net income	-49.7% Weak ↓ Weak Declining Year-over-year change in net income	-4.6% Weak ↑ Weak Improving Year-over-year change in net income	23.1% Good ↑ Good Improving Year-over-year change in net income	-51.7% Weak Weak Year-over-year change in net income	-1532.2% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	N/M	51.6% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	80.8% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	15.1% Good ↑ Good Improving Year-over-year change in free cash flow	25.5% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	4.8% Caution Caution Year-over-year change in free cash flow	-105.9% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	27.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	5.2% Fair ↑ Fair Improving Compound annual revenue growth over 3 years	-7.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-11.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-2.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	67.2% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	14.7% Good ↓ Good Declining Compound annual revenue growth over 3 years	12.7% Good ↓ Good Declining Compound annual revenue growth over 3 years	9.6% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	499.3% Excellent Excellent Compound annual revenue growth over 3 years	-31.3% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	8.4% Good ↑ Good Improving Compound annual revenue growth over 5 years	-2.6% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-1.0% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	27.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	2.6% Caution ↓ Caution Declining Compound annual revenue growth over 5 years	11.3% Good ↓ Good Declining Compound annual revenue growth over 5 years	44.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	205.7% Excellent Excellent Compound annual revenue growth over 5 years	-34.8% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	-43.8% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Operating Margin (%) (%)	-3.4% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-122%)	-72.9% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-586%)	-97.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-751%)	-179.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1294%)	-466.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3207%)	-414.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2862%)	-343.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2388%)	-395.5% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2737%)	—	-371.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2573%)	-431.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2979%)	—	—	-7.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-149%)	—
Effective Tax Rate (%) (%)	18.1% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-26.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-12.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	3.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	4.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-5.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-5.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.8% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	98.5% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+721%)	-87.6% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-830%)	-96.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-901%)	—	-360.6% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3105%)	-386.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3324%)	-322.1% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2784%)	-357.0% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3075%)	—	-391.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3366%)	-432.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3705%)	—	—	-7.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-161%)	—
FCF Margin (%) (%)	222.0% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-17.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-47.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-364.2% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-375.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-348.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-324.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-187.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-203.5% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—
FCF / Net Income (x)	2.25x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.20x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.21x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.90x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.52x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.70x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.52x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Return on Invested Capital (%)	-1.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-33.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-29.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-92.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-91.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-106.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-56.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-80.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-54.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-75.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-82.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	917.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	137.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-0.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-68.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-63.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-61.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-42.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-58.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-60.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-68.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	-620.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	35.7% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+138%)	-32.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-314%)	-25.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-273%)	197.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1216%)	58.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+293%)	91.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+510%)	105.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+604%)	—	-247.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1752%)	-54.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-463%)	-75.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-600%)	-81.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-645%)	—	137.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+813%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Debt to Equity (x)	—	—	0.00x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	-1.82x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-403%)	-2.04x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-440%)	-2.03x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-439%)	-8.81x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-1568%)	1.94x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+224%)	—	—	—	—	—	—
Interest Coverage (x)	—	—	-23.84x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-14.44x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-30.16x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.68x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.91x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-22.78x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-30.43x Weak Weak Operating income divided by interest expense Optimal: > 5x	-128.54x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—
Net Debt (USD)	$-167.81M	$-37.80M	$-39.55M	$-298.17M	$526.38M	$537.70M	$396.98M	$76.33M	$134.77M	$-344.71M	$-112.71M	$-89.22M	$0.00	$0.00	—
Debt / EBITDA (x)	—	—	0.00x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-2.42x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-2.10x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.83x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.93x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.87x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Revenue per Share (USD)	$2.14	$1.32	$1.04	$0.70	$0.80	$1.15	$1.30	$1.10	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$2.10	$-1.15	$-1.00	$11.85	$-2.87	$-4.46	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$4.74	$-0.24	$-0.49	$-2.54	$-2.99	$-4.02	$-4.22	$-2.05	—	—	—	—	—	—	—
Book Value per Share (USD)	$5.81	$3.55	$4.43	$6.77	$-4.55	$-4.72	$-3.93	$-0.93	$2.12	$6.63	$6.40	$8.99	—	—	—
Tangible Book Value per Share (USD)	$5.81	$3.55	$4.43	$6.77	$-4.55	$-4.72	$-3.93	$-0.93	$2.12	$6.63	$6.40	$8.99	—	—	—
Basic Weighted Avg Shares (shares)	50.32M	48.85M	55.30M	73.59M	69.46M	62.34M	56.45M	55.08M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Working Capital (USD)	$380.16M	$128.98M	$108.77M	$324.75M	$191.28M	$269.77M	$226.78M	$434.27M	$316.20M	$479.24M	$188.00M	$234.11M	$-22.75M	—	—
LT Debt (USD)	—	—	$0.00	—	$616.33M	$619.17M	$455.04M	$454.35M	$223.75M	—	—	—	—	—	—
Total Equity (USD)	$296.72M	$175.54M	$213.00M	$441.80M	$-338.57M	$-303.75M	$-223.84M	$-51.59M	$115.18M	$350.23M	$243.06M	$289.79M	$-17.04M	$-6.99M	$-140.72M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗
Sales/Revenue/Turnover (USD)	$107.46M	$64.38M	$57.42M	$51.35M	$55.31M	$71.86M	$73.41M	$60.37M	$15.39M	$48.65M	$42.13M	$11.69M	$226.00K	$130.15M	—
Depreciation Expense (USD)	$1.50M	$1.60M	$1.90M	$2.60M	$3.50M	$3.30M	$3.30M	$3.00M	$4.03M	$3.12M	$2.99M	$3.27M	$2.65M	$3.25M	—
Net Income, GAAP (USD)	$105.89M	$-56.42M	$-55.19M	$872.13M	$-199.43M	$-278.02M	$-236.46M	$-215.52M	$-285.40M	$-190.67M	$-182.22M	$-237.04M	$-156.28M	$-9.57M	—
Operating Cash Flow (USD)	$238.54M	$-11.54M	$-27.00M	$-186.99M	$-207.86M	$-250.40M	$-238.20M	$-112.87M	$-201.05M	$-98.99M	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 15 years · 55 quarters

Theravance Biopharma, Inc.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TBPH with peers